| 标题 |
Venetoclax added to dose-adjusted EPOCH-R for newly diagnosed double-hit lymphomas: phase 2 results from ALLIANCE A051701, an open-label, randomised, controlled, phase 2–3 trial |
| 网址 | |
| DOI |
10.1016/S2352-3026(26)00191-2
doi
|
| 其它 |
期刊:The Lancet Haematology 作者:Jeremy Abramson; Susan Geyer; Sharmila Giri; Levi Pederson; Ann Hudson; et al 出版日期:2026-08-28 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)